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IntroductIon
Ito cells belong to the non-parenchymal liver cells 
and are located in the perisinusoidal space of Disse. 
In 1876 Carl von Kupffer was the first who described 
a type of hepatic stellate cells, located in this space. 
Based on his observations and studies, Kupffer de-
scribed them as phagocytic cells1. Several decades lat-
er, in 1951, the Japanese Professor of Anatomy Toshio 
Ito observed lipid droplets in the cytoplasm of these 
hepatic stellate cells and described them as fat storing 
cells. Since then, these cells were named after him and 
are nowadays known as Ito cells. However, there are 
a lot of other names which are also used when refer-
ring to Ito cell, such as pericytes, perisinusoidal cells, 
lipocytes, fat storing cells and of course hepatic stel-
late cells2. 
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ABStrAct: Introduction-Aim of the study: Ito cells are the hepatic stellate cells in the space of Disse. They play a key 
role in the development and regeneration of liver. Retinoid analogues are used therapeutically, while hydroxyurea (HU) is 
an antiretroviral and chemotherapeutic agent. The aim of this study is to evaluate the effect of the above substances on Ito 
cells’ ultrastructural morphology by TEM observations.
Materials-Methods: Six groups of pregnant Balb/C mice were used for the study. All animals were treated on gestational 
days 10th, 11th, 12th. The first group was treated with All-Trans Retinoic Acid (RA), the second group with Retinyl Palmitate 
(RP), the third group with a combination of 13-cis RA and RP and the fourth group with HU. The fifth and the sixth groups 
were the control animals. Animals were sacrificed on the 19th gestational day. Livers from all animals were removed and 
were properly prepared for TEM observation.
Results: Observation of the liver of All-Trans RA treated pregnant animals revealed Ito cell activation. Microbodies simi-
lar to peroxisomes and lysosomes were present in their cytoplasm. Similar findings were found in RP treated animals. In 
the activated stellate cells, the presence of microfibrils around their nuclei appeared with chromatin condensation in the 
periphery. In the liver of animals treated with a combination of RP and 13-Cis RA, microfibrils in the cytoplasm, fibrosis 
and extracellular edema were observed around the sinusoids. In the liver of HU treated animals, peroxisomes with different 
density were observed in the hepatocyte cytoplasm, surrounded by lipid droplets. In the cytoplasm of activated Ito cells, low 
density peroxisomes were observed. Fibrosis and extracellular edema were observed surrounding the sinusoids among the 
stellate cells and in the space of Disse.
Conclusions: This ultrastructural study indicates that the drugs induced Ito cell activation and caused possibly irreversible 
damage to liver parenchyma.
Key Words: Ito cells, Ultrastructural morphology, Liver, Teratogenic drugs, Retinoids, hydroxyurea.
Corresponding author: Elpida-Niki Emmanouil-Nikoloussi, Professor of Histology-Embryology & Anthropology, Faculty 
of Medicine, Aristotle University of Thessaloniki, University Campus, Thessaloniki, 54124, Greece, Tel: +30 2310 999148, 
+30 2310 999066, Fax: +30 2310 999189, email: emmanik@med.auth.gr
20 Aristotle University Medical Journal, Vol. 36, Issue 3, October 2009
There is a controversial point of view for Ito cell 
origin. However recently, Baba et al through their re-
search studies demonstrated that Ito cells originate 
from mesenchyme3.
Ito cells are known to have at least four distinct 
functions. They store and release retinoids, they are in-
volved in the construction and breakdown of extracel-
lular matrix, they regulate blood flow in the sinusoids 
and they produce mediators and cytokines4. Hepatic 
stellate cells play a key role in hepatocellular function 
by interfering in the development and the regeneration 
of the liver5 through extracellular matrix component 
synthesis, not only under normal conditions, but in 
liver fibrosis as well6,7. Under pathological liver con-
ditions or after liver injury of any cause, Ito cells are 
transformed from a quiescent state into activated cells 
which produce extracellular matrix proteins, such as 
collagen, glycoprotein and proteoglycan8.
AIM oF tHE StudY
The retinoid analogues 13-cis Retinoic Acid (13-cis 
R.A.), All-Trans Retinoic Acid (All-Trans R.A.) and 
Retinyl Palmitate (R.P.), are used therapeutically for 
several mucosal and skin diseases. Additionally, All-
Trans Retinoic Acid is used as a chemotherapeutic 
agent in acute promyelocytic leukemia. Hydroxyurea 
(HU) is used in antiretroviral therapy and as a che-
motherapeutic drug. These drugs are considered to 
be teratogenic and toxic agents. On the other hand, it 
has been described that Ito cells are activated under 
pathological conditions, such as toxicity of drugs. In 
the present study we observed the effect of the above 
substances on the ultrastructural morphology of liver 
stellate cells, when administrated during early em-
bryogenesis- organogenesis of mice.
MAtErIALS And MEtHodS
For this study, we treated six (6) groups of pregnant 
Balb/C mice approximately 30gr, on gestational days 
10th, 11th and 12th with: Group 1) All-Trans Retinoic 
Acid 50 mg/k.b.w., Group 2) Retinyl Palmitate 30 mg/
k.b.w., Group 3) 13-cis Retinoic Acid 50 mg/k.b.w. 
combined with Retinyl Palmitate 30 mg/k.b.w., Group 
4) Hydroxyurea, HU 4,50 mg/k.b.w., Group 5) Corn 
oil, 1 ml and Group 6) NaCl 9‰ 1 ml. The last two 
groups were the control animal groups. The pregnant 
animals were sacrificed on the 19th gestational day. 
Livers from pregnant animals were removed and 
tissue biopsies were taken from the center of the right 
liver lobe. The samples were cut in small tissue items 
(1 mm3), they were immediately immersed and fixed 
with glutaraldehyde 3% for two hours in 4 °C, post-
fixed for one hour in 2% osmium tetroxide (OsO4) and 
“in tissue” stained with uranyl acetate 1% and lead 
citrate. Tissue samples were dehydrated in a degraded 
series of ethanol solutions and they were finally em-
bedded in Epon resin fixative. Semithin tissue sections 
0,5 μm thick were cut and were stained with toluidine 
blue 2% and intralobular spaces were located under 
light microscope. Ultrathin sections 600-700 Å were 
table 1. Animal groups, number of animals and drugs
Animal Groups Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
number of Pregnant 
Animal 
5 5 5 5 5 5
drug All-Trans 
R.A.
R.P. 13-cis R.A.  
and R.P.
HU Corn Oil- 
(Control)
NaCl 9‰ 
(Control)
dosage level 50 mg/
k.b.w
30 mg/
k.b.w
50+30 
mg/k.b.w
4,50 mg/
k.b.w
1 ml 1 ml
Gestational days  
of treatment
10th, 11th 
and 12th
10th, 11th 
and 12th
10th, 11th and 
12th
10th, 11th 
and 12th
10th, 11th 
and 12th
10th, 11th  
and 12th
All-Trans R.A.: All-Trans Retinoic Acid 
R.P.: Retinyl Palmitate 
13-cis R.A. and R.P.: 13-cis Retinoic Acid and Retinyl Palmitate
HU: Hydroxyurea
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obtained with an ultramicrotome (Leica EM UC6), 
they were post-stained with lead citrate and observed 
with the use of Transmission Electron Microscope 
(Jeol 2000 FX, Tokyo, Japan). Photomicrographs 
from all liver tissue samples were observed in several 
magnifications.
rESuLtS
Ultrastructural observation of the liver from the control 
animals (Groups 5 and 6), revealed the expected mor-
phology of Ito perisinusoidal cells and the expected 
lipid concentration. Stellate cells were located in the 
periphery of sinusoidal capillary vessels and the lipid 
droplets were located inside their cytoplasm (Figures 
1, 2, 3, 4). The surrounding capillaries appeared to 
have a normal endothelium and the liver parenchyma 
did not have any noticeable edema or fibrosis.
Observation of the liver of All-Trans Retinoic Acid 
treated pregnant animals (Group 1), revealed the acti-
vation of Ito perisinusoidal cells, since lipid droplets 
Group 5. Corn oil treated control.
Figures 1 and 2. Ultrathin sections of liver tissue from Group 5 (Corn oil control treated animals). Normal morphology 
of Ito perisinusoidal cells and lipid concentration as expected. Stellate cells located in the periphery of sinusoidal capillary 
vessels with lipid droplets located inside their cytoplasm. Magnification x 5.000.
Group 6. NaCl 9‰ treated control.
Figures 3 and 4. Ultrathin sections of liver tissue from Group 6 (NaCl 9‰ control treated animals). Normal morphology 
of Ito perisinusoidal cells and lipid concentration as expected. Stellate cells located in the periphery of sinusoidal capillary 
vessels with lipid droplets located inside their cytoplasm. Magnification x 5.000.
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were not observed inside their cytoplasm. Moreover, 
microbodies containing fine granular matrix similar to 
peroxisomes (Figure 5) and lysosomes (Figures 5, 6 
and 7) were present in their cytoplasm. Similar find-
ings were found in Retinyl Palmitate treated animals 
(Group 2). An important finding in the activated stel-
late cells was the presence of microfibrils around their 
nuclei, which appeared with chromatin condensation 
in the periphery (Figures 8 and 9). In the liver of ani-
mals treated with a combination of Retinyl-Palmitate 
and 13-Cis retinoic Acid (Group 3), apart from the mi-
crofibrils in the cytoplasm, fibrosis and extracellular 
edema were observed around the sinusoids (Figures 
10 and 11). In the liver of Hydroxyurea treated ani-
mals (Group 4), more striking findings were observed. 
Peroxisomes with different density were observed in 
the hepatocyte cytoplasm, surrounded by lipid drop-
lets. In the cytoplasm of activated Ito cells low density 
peroxisomes were observed (Figure 12). Fibrosis and 
extracellular edema were observed surrounding the 
Group 1. All-Trans R.A. treated.
Figure 5. Ultrathin section of liver tissue from Group 1 (All-Trans R.A. treated animals). Activation of Ito perisinusoidal 
cells without lipid droplets inside their cytoplasm. Microbodies containing fine granular matrix similar to peroxisomes and 
lysosomes were observed inside Ito perisinusoidal cell cytoplasm. 
Magnification x 5.000.
Figure 6. Ultrathin section of liver tissue from Group 1 (All-Trans R.A. treated animals). Lysosomes were observed inside 
Ito perisinusoidal cell cytoplasm. Magnification x 6.000.
Figure 7. Ultrathin section of liver tissue from Group 1 (All-Trans R.A. treated animals). Lysosomes were observed inside 
Ito perisinusoidal cell cytoplasm. Magnification x 8.000.
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sinusoids among the stellate cells and in the space of 
Disse (Figures 13, 14 and 15).
dIScuSSIon
It has been described that up to 80% of the human 
body’s vitamin A is stored in the liver. Under normal 
conditions Ito cells are the main site of vitamin A stor-
age. This is stored in the form of retinyl palmitate in 
cytoplasmic lipid droplets which exert a major role in 
the homeostasis of the vitamin. It has been described 
that Ito cells which are located in periportal regions 
store much more vitamin A than those lying in peri-
central regions9,10. Vitamin A enters Ito cells as a com-
plex (vitamin A - Retinol Binding Protein) by means 
of endocytosis11. This procedure is mediated through 
Retinol Binding Protein receptors which are expressed 
on Ito cell surface9. Hepatic stellate cells have also 
been found to contain large amounts of cholesterol, 
triglycerides and free fatty acids5,12. Furthermore, pro-
teins that are involved in retinoid metabolism have 
Group 2. Retinyl Palmitate treated.
Figures 8 and 9. Ultrathin sections of liver tissue from Group 2 (Retinyl Palmitate treated animals). Activated stellate cells 
with microfibrils around their nuclei. Magnifications x 5.000 (8), x 8.000 (9).
Group 3. Retinyl-Palmitate and 13-Cis Retinoic Acid treated.
Figures 10 and 11. Ultrathin sections of liver tissue from Group 3 (combination of Retinyl-Palmitate and 13-Cis Retinoic 
Acid treated animals). Fibrosis and extracellular edema were observed around the sinusoids. Microfibrils were observed in 
stellate cell cytoplasm.Magnification x 5.000.
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also been identified, among which retinol palmitate 
hydrolase, cellular retinol-binding protein and cellular 
retinoic acid-binding protein13,14. 
Ito cell activation is a two-stage process includ-
ing a) initiation, which is also called “proinflamma-
tory” stage and which is the phase of stimulation (with 
stimuli from neighboring cells and from injured liver 
parenchyma) and b) perpetuation, which includes a se-
quence of events as a result of Ito cell response to the 
stimuli of the first phase. These events of the second 
stage are described by Friedman and include: prolifer-
ation of hepatic stellate cells, cytokine release-chemot-
axis-WBC chemoattraction, fibrogenesis, degradation, 
contractility and retinoid loss15. During activation Ito 
cells proliferate, lose their initial star shape and trans-
form from quiescent and rich in vitamin A cells into 
deficient in vitamin A proliferative cells. These new 
cells look like myofibroblasts and are contractile. 
This process is also known as “transdifferentiation”16. 
Anti-desmin antibody is a marker of quiescent (non 
activated) stellate cells, while anti-alpha-smooth ac-
tin antibody is a marker of activated stellate cells17. 
Activated Ito cells proliferate and synthesize large 
amounts of extracellular matrix proteins and thus they 
Group 4. Hydroxyurea treated.
Figure 12. Ultrathin section of liver tissue from Group 4 (Hydroxyurea treated animals). Peroxisomes with different density 
were observed in hepatocyte cytoplasm, surrounded by lipid droplets. Activated Ito cells with low density peroxisomes in-
side their cytoplasm. Magnification x 5.000.
Figures 13 - 15. Ultrathin sections of liver tissue from Group 4 (Hydroxyurea treated animals). Fibrosis and extracellular 
edema surrounding the sinusoids and among the stellate cells in Disse space. Magnification x 5.000.
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are thought to play a major and crucial role in hepatic 
fibrogenesis18. In recent years several papers deal with 
Ito cells in health and disease. Kazuhiko Besshi et al 
studied the liver of rats fed with a choline deficient 
diet, which is known to cause fatty liver and hepatic 
fibrosis, under light and electron microscopy. This 
was done in an effort to find out whether it is the re-
duction of Vitamin A in hepatic stellate cells that in-
duces fibrosis or fibrosis that causes the reduction of 
vitamin A lipid droplets in Ito cells. The writers were 
the first to present evidence, with the help of light and 
electron microscopy, that activation of quiescent Ito 
cells comes 2 weeks before induction of fibrosis, thus 
concluding that it is the transformation of Ito cells that 
causes liver fibrosis19. 
Higashi et al used an electron microscope to study 
rat livers that had undergone partial hepatectomy 
and found out that the lipid droplets with vitamin A 
decreased in number until the third day after hepa-
tectomy and returned to normal levels 2 weeks after 
the surgical procedure. Their results suggest that Ito 
cells may change their ability to store Vitamin A dur-
ing liver regeneration20. Another important role of 
the hepatic stellate cells is that of immunoregulation 
through their action as intrahepatic antigen present-
ing cells21. Moreover, Ito cells seem to participate 
and enhance the inflammatory response since they 
produce chemoattractants for polymorphonuclear and 
mononuclear leucocytes thus causing their infiltration 
in the tissues5. It is mentioned in the literature that a 
great variety of other biological agents are also pro-
duced and secreted by Ito cells such as lipoproteins, 
e.g. Apolipoprotein E and prostaglandines22 including 
PGE1 and PGE223.
A great number of transforming growth factors and 
cytokines have also been found to be associated with 
hepatic stellate cells. Indicatively, we mention the 
epidermal growth factor24, the platelet derived growth 
factor25, fibroblast growth factors a-FGF and b-FGF26, 
as well as cytokines such as serotonin27, endothelin-
128,29 and thrombin30.
Several studies have been made in order to clarify 
the exact role of Vitamin A on hepatic stellate cell 
activation, which could help us understand better the 
mechanism of liver fibrosis. Nevertheless, it is still 
not clear whether vitamin A inhibits or promotes the 
activation process. Davis et al studied the effects of 
retinoic acid on hepatic stellate cell lines concerning 
the cell proliferation and collagen production. They 
found out that retinoic acid not only had a strongly 
inhibitory role on cell proliferation, but they also ob-
served a decrease in collagen production. Their find-
ings “in vitro” are indicative of a regulatory role of 
retinoic acid in hepatic stellate cell activation, and in 
liver fibrosis31.
Hellemans et al also studied “in vitro” the effect 
of All-Trans Retinoic Acid and 9-cis Retinoic Acid 
on the proliferation of activated hepatic stellate cells 
and on the synthesis of the components of extracel-
lular matrix. According to their study these two potent 
Vitamin A derivatives do not exert similar effects on 
activated hepatic stellate cells i.e. different forms of 
retinoic acid affect hepatic stellate cells in different 
ways. More specifically, All-Trans Retinoic Acid was 
found to induce the reduction of synthesis of extracel-
lular matrix proteins such as fibronectin, laminin and 
collagen types I and III, without affecting the prolif-
eration of the activated hepatic stellate cells. On the 
other hand, treatment with 9-cis Retinoic Acid caused 
a reduction up to 35% in the proliferation of the acti-
vated hepatic stellate cells, while only collagen type I 
synthesis was reduced32.
Similar research studies on “in vitro” response of 
activated hepatic stellate cells’ after exposure to natu-
ral and synthetic retinoic acids concluded that the lat-
ter have a different impact on Ito cell proliferation and 
on collagen and fibronectin production33.
According to our observations the teratogenic 
drugs All-Trans Retinoic Acid, Retinyl Palmitate, 13-
Cis Retinoic Acid and Hydroxyurea can activate Ito 
stellate cells and can cause possibly irreversible dam-
age to liver parenchyma.
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